Sign in

CIK 0000842023 · Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
operating
EIN
411427402
Phone
612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-10-26 Kummeth Charles R. Chief Executive Officer Grant or award · Stock Options (Right to buy) +117,342 117,342
2017-10-26 Kummeth Charles R. Chief Executive Officer Grant or award · Stock Options (Right to buy) +78,228 78,228
2017-10-26 Seth Alpna Director Grant or award +739 739
2017-10-26 Seth Alpna Director Grant or award · Stock Options (Right to buy) +3,125 3,125
2017-10-26 STEER RANDOLPH C Director Grant or award +739 3,712
2017-10-26 STEER RANDOLPH C Director Grant or award · Stock Option (right to buy) +3,125 3,125
2017-10-26 Bazan J. Fernando Chief Technical Officer Grant or award · Restricted Stock Units +1,649 1,649
2017-10-26 Bazan J. Fernando Chief Technical Officer Grant or award · Stock Options (Right to buy) +9,089 9,089
2017-10-26 Bazan J. Fernando Chief Technical Officer Grant or award · Stock Options (Right to buy) +12,119 12,119
2017-10-26 BAUMGARTNER ROBERT V Director Grant or award +739 7,712
2017-10-26 BAUMGARTNER ROBERT V Director Grant or award · Stock Option (right to buy) +3,125 3,125
2017-10-26 Furlow Brenda S. SVP - General Counsel Grant or award · Restricted Stock Units +1,724 1,724
2017-10-26 Furlow Brenda S. SVP - General Counsel Grant or award · Stock Options (Right to buy) +9,503 9,503
2017-10-26 Furlow Brenda S. SVP - General Counsel Grant or award · Stock Options (Right to buy) +12,670 12,670
2017-10-26 Gavin Robert M. Sen. VP Protein Platforms Grant or award · Restricted Stock Units +1,949 1,949
2017-10-26 Gavin Robert M. Sen. VP Protein Platforms Grant or award · Stock Options (Right to buy) +10,742 10,742
2017-10-26 Gavin Robert M. Sen. VP Protein Platforms Grant or award · Stock Options (Right to buy) +14,323 14,323
2017-10-26 Gould Kevin S SVP Clinical Controls Grant or award · Restricted Stock Units +1,949 1,949
2017-10-26 Gould Kevin S SVP Clinical Controls Grant or award · Stock Options (Right to buy) +10,742 10,742
2017-10-26 Gould Kevin S SVP Clinical Controls Grant or award · Stock Options (Right to buy) +14,323 14,323

Page 57 of 64 · 1,274 trades